Intensity Therapeutics, Inc. (INTS)

Price & Market Data

Price: $4.90

Daily Change: -$0.10 / 2.04%

Daily Range: $4.75 - $5.13

Market Cap: $12,929,985

Daily Volume: 41,059

Performance Metrics

1 Week: -6.28%

1 Month: -10.62%

3 Months: -47.88%

6 Months: -57.11%

1 Year: -63.72%

YTD: -52.41%

About Intensity Therapeutics, Inc. (INTS)

Quick market take on Intensity Therapeutics, Inc. (INTS). Current price: 4.90, daily change: -$0.10 / 2.04%. Market cap: 12,929,985. Performance over 1-week and 1-month.

Company Details

Employees: 16

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.

Selected stocks

Bain Capital GSS Investment Corp. (BCSS-UN)

Merchants Bancorp - Depositary Shares, Each Representing a 1/40th Interest in a Share of 7.625% Fixed Rate Series E Non-Cumulative Perpetual Preferred Stock, wi (MBINL)

Ondas Inc (ONDS)

First Merchants Corporation - Depository Shares, each representing a 1/100th interest in a share of 7.50% Non-Cumulative Perpetual Preferred Stock, A (FRMEP)

Liminatus Pharma, Inc. (LIMN)